| Colten S Marlin, PT | |
|
1310 Sidney St, Batesville, AR 72501-7628 | |
| (870) 612-7200 | |
| (870) 612-7200 |
| Full Name | Colten S Marlin |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 9 Years |
| Location | 1310 Sidney St, Batesville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184000465 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT 4029 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gross Therapy Services Inc | 5991072050 | 30 |
News Archive
Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don't die from cancer itself, rather from heart and blood vessel conditions.
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke.
› Verified 8 days ago
| Provider Name | Batesville Therapy Clinic, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194716258 PECOS PAC ID: 8921086125 Enrollment ID: O20040713001082 |
News Archive
Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don't die from cancer itself, rather from heart and blood vessel conditions.
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke.
› Verified 8 days ago
| Provider Name | Gross Therapy Services Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1033236468 PECOS PAC ID: 5991072050 Enrollment ID: O20170522002316 |
News Archive
Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don't die from cancer itself, rather from heart and blood vessel conditions.
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colten S Marlin, PT 1310 Sidney St, Batesville, AR 72501-7628 Ph: (870) 612-7200 | Colten S Marlin, PT 1310 Sidney St, Batesville, AR 72501-7628 Ph: (870) 612-7200 |
News Archive
Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don't die from cancer itself, rather from heart and blood vessel conditions.
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).
People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke.
› Verified 8 days ago
Betty Bradley, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1610 Harrison St Ste A, Batesville, AR 72501 Phone: 870-262-1271 | |
Mr. Justin D Hoskinds, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1310 Sidney St, Batesville, AR 72501 Phone: 870-612-7200 Fax: 870-612-7203 | |
Mkjd, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3500 Fax: 870-793-3501 | |
Integrated Therapy Services Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3246 Harrison St, Batesville, AR 72501 Phone: 870-248-1448 Fax: 870-248-1450 | |
Dr. Caren E Barnett, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1710 Harrison Street, Batesville, AR 72501 Phone: 870-262-1200 | |
Mrs. Brooklyn Leigh Taylor, PT DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2080 Harrison St Ste A, Batesville, AR 72501 Phone: 870-569-8167 Fax: 870-277-0896 | |
Hunter Finney, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1699 Harrison St, Batesville, AR 72501 Phone: 870-262-1271 |